Trial Profile
CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 MICROGRAM/GRAM WITH THREE CONCENTRATIONS (100, 250, 500 MICROGRAM/GRAM) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ PSORIASIS MINI PLAQUE TEST UNDER NON-OCCLUSIVE CONDITIONS.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2022
Price :
$35
*
At a glance
- Drugs Calcitriol/clobetasol (Primary) ; Betamethasone-dipropionate/calcipotriol; Clobetasol
- Indications Plaque psoriasis
- Focus First in man; Therapeutic Use
- 31 Mar 2022 Status changed from recruiting to completed (Date of the global end of the trial 14 May 2007)
- 12 Jul 2011 New trial record